These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9494530)

  • 1. Role of chemotherapeutic antagonism in opportunistic infections.
    Castelli M; Baggio G; Ruberto AI; Malagoli M; Casolari C; Rossi T; Galatulas I
    Anticancer Res; 1997; 17(6D):4339-44. PubMed ID: 9494530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The postantibiotic effect induced by antimicrobial combinations.
    Gudmundsson S; Erlendsdóttir H; Gottfredsson M; Gudmundsson A
    Scand J Infect Dis Suppl; 1990; 74():80-93. PubMed ID: 2129068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the cell wall on ciprofloxacin susceptibility in selected wild-type Gram-negative and Gram-positive bacteria.
    Berlanga M; Montero MT; Hernández-Borrell J; Viñas M
    Int J Antimicrob Agents; 2004 Jun; 23(6):627-30. PubMed ID: 15194135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibiotic sensitivity of microorganisms, isolated from patients with opportunistic infections].
    Tymchyk OV; Shapiro AV; Vasylenko OH
    Mikrobiol Z; 2005; 67(5):64-8. PubMed ID: 16396113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
    Wang FD; Lin ML; Lee WS; Liu CY
    Int J Antimicrob Agents; 2004 Jun; 23(6):590-5. PubMed ID: 15194130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ; Su DH; Jiang JH; Zhong NS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the use o f Gunnera perpensa extracts in endometritis related to antibacterial activity?
    McGaw LJ; Gehring R; Katsoulis L; Eloff JN
    Onderstepoort J Vet Res; 2005 Jun; 72(2):129-34. PubMed ID: 16137130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens.
    Vouillamoz J; Moreillon P; Giddey M; Entenza JM
    J Antimicrob Chemother; 2008 Feb; 61(2):371-4. PubMed ID: 18033780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism and antagonism.
    Eliopoulos GM
    Infect Dis Clin North Am; 1989 Sep; 3(3):399-406. PubMed ID: 2671129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial pathogens (non-Mycobacterium) from sputum culture and antimicrobial susceptibility.
    Srifuengfung S; Sangsawang M; Komolpis P; Dhiraputra C; Chompanee B
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):96-9. PubMed ID: 9740278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents.
    Gradelski E; Kolek B; Bonner DP; Valera L; Minassian B; Fung-Tomc J
    Int J Antimicrob Agents; 2001 Feb; 17(2):103-7. PubMed ID: 11165113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
    Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
    Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of drug resistance spectrum and its mechanism in 1017 clinical bacterial isolates].
    Geng SN; Rui YY; Wang Q; Mou CH; Zhou XH; Zhang J
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1529-32, 1545. PubMed ID: 16361155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interaction of neomycin with other antibiotics on selected bacterial strains].
    Grzybowska W; Wójcik A; Tyski S
    Med Dosw Mikrobiol; 2004; 56(2):187-98. PubMed ID: 15544091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
    Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro interactions of carumonam in combination with coumermycin, teicoplanin, flucloxacillin and vancomycin.
    Machka K; Milatovic D; Braveny I
    Chemioterapia; 1987 Jun; 6(2 Suppl):117-8. PubMed ID: 2978385
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythromycin synergism with essential and trace elements.
    Sultana N; Arayne MS; Sabri R
    Pak J Pharm Sci; 2005 Apr; 18(2):35-9. PubMed ID: 16431396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
    Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT
    J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.